Large-scale testing (Phase 3)Study completedNCT05158140
What this trial is testing
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)
Who this might be right for
Pneumococcal Infection
Merck Sharp & Dohme LLC 850